A Pilot Study to Evaluate Radiotherapy-Induced Anti-Tumor Immunity in Metastatic Carcinoma of the Pancreas

Histological or Cytological Diagnosis of Pancreatic Carcinoma Clinical Trial

Official title: A Pilot Study to Evaluate Radiotherapy-Induced Ant-Tumor Immunity in Metastatic Carcinoma of the Pancreas

Status Completed

Clinical Trial Summary

Primary Objective: To estimate the rate at which radiotherapy to the primary or a metastatic lesion produces an immune response in patients with metastatic carcinoma of the pancreas.

Secondary Objectives: To characterize the kinetics of an immune response induced by radiotherapy. To characterize the dependency of the immune response on prior exposure to chemotherapy.

Clinical Trial Description

n/a

Related Conditions & MeSH terms

• Carcinoma
• Histological or Cytological Diagnosis of Pancreatic Carcinoma
• Pancreatic Neoplasms

• NCT number: NCT01985958
• Study type: Interventional
• Source: Abramson Cancer Center of the University of Pennsylvania
• Status: Completed
• Phase: N/A
• Start date: July 2013
• Completion date: December 2019